LONG-TERM OUTCOMES OF RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH END-STAGE RENAL DISEASE AND ATRIAL FIBRILLATION: A 1- AND 3-YEAR PROPENSITY-MATCHED ANALYSIS.

Saved in:
Bibliographic Details
Title: LONG-TERM OUTCOMES OF RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH END-STAGE RENAL DISEASE AND ATRIAL FIBRILLATION: A 1- AND 3-YEAR PROPENSITY-MATCHED ANALYSIS.
Authors: Issa, Rochell (AUTHOR), Motairek, Issam (AUTHOR), Calcagno, Tess (AUTHOR), Tabaja, Chadi (AUTHOR), Issa, Ryan (AUTHOR), Collier, Patrick (AUTHOR), Agdamag, Arianne Clare C. (AUTHOR), Sadler, Diego B. (AUTHOR), Moudgil, Rohit (AUTHOR)
Source: Journal of the American College of Cardiology (JACC). 2025 Supplement, Vol. 85 Issue 12, p271-271. 1p.
Database: Academic Search Ultimate
Description
ISSN:07351097
DOI:10.1016/S0735-1097(25)00756-9